NCT04832932: The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes |
|
|
| Active, not recruiting | N/A | 2000 | Europe, US, RoW | COVID-19 vaccines, BNT162b2, mRNA-1273, JNJ-78436735, AZD1222, Gam-KOVID-Vak, CoronaVac/Sinovac, BBIBP-CorV, BBV152, NVX-CoV2373 | Mebo Research, Inc., Aurametrix | COVID-19 Vaccines | 01/23 | 01/25 | | |